Apogee Therapeutics, Inc.
APGE
Cena:
$ 81.16
-1.27 (-1.54%)
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| OCTAGON CAPITAL ADVISORS LP | 10.7 mil | 18.39% | 2.61% | 2.61% | 2025-03-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 10.3 mil | 16.97% | 0.47% | 0.60% | 2025-06-30 |
| FMR LLC | 9.3 mil | 15.26% | 0.01% | 0.04% | 2023-09-30 |
| VR ADVISER, LLC | 8.5 mil | 13.99% | -4.98% | 26.68% | 2023-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 4.4 mil | 7.21% | 0.01% | 0.07% | 2023-09-30 |
| BLACKROCK, INC. | 4.1 mil | 6.73% | 0.00% | 0.01% | 2024-09-30 |
| VANGUARD GROUP INC | 2.9 mil | 4.86% | 0.00% | 0.00% | 2023-09-30 |
| RTW INVESTMENTS, LP | 2.8 mil | 4.58% | 0.28% | 2.33% | 2023-09-30 |
| JANUS HENDERSON GROUP PLC | 2.4 mil | 3.89% | 0.03% | 0.09% | 2023-09-30 |
| STATE STREET CORP | 2.2 mil | 3.56% | 0.00% | 0.01% | 2023-09-30 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.9 mil | 3.16% | 0.07% | 1.19% | 2023-09-30 |
| RA CAPITAL MANAGEMENT, L.P. | 1.6 mil | 2.70% | 0.03% | 0.98% | 2023-09-30 |
| PERCEPTIVE ADVISORS LLC | 1.5 mil | 2.54% | -0.60% | 2.54% | 2023-09-30 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.3 mil | 2.22% | 0.15% | 2.32% | 2024-03-31 |
| AFFINITY ASSET ADVISORS, LLC | 1.3 mil | 2.12% | 0.27% | 5.59% | 2023-09-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.2 mil | 2.11% | 0.07% | 0.10% | 2023-09-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2 mil | 2.01% | 0.00% | 0.01% | 2023-09-30 |
| UBS GROUP AG | 1.1 mil | 1.89% | 0.00% | 0.01% | 2023-09-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.1 mil | 1.88% | 0.00% | 0.01% | 2023-09-30 |
| JPMORGAN CHASE & CO | 1.1 mil | 1.83% | 0.00% | 0.01% | 2023-09-30 |
| VESTAL POINT CAPITAL, LP | 1.1 mil | 1.81% | 1.18% | 2.59% | 2025-09-30 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.1 mil | 1.75% | 0.54% | 0.92% | 2024-03-31 |
| ALLIANCEBERNSTEIN L.P. | 990.30 tis | 1.63% | 0.00% | 0.02% | 2023-12-31 |
| BANK OF AMERICA CORP /DE/ | 900.87 tis | 1.48% | 0.00% | 0.01% | 2023-09-30 |
| MERCER GLOBAL ADVISORS INC /ADV | 831.43 tis | 1.37% | 0.00% | 0.10% | 2024-12-31 |
| GOLDMAN SACHS GROUP INC | 652.59 tis | 1.08% | 0.00% | 0.01% | 2023-09-30 |
| SIREN, L.L.C. | 594.99 tis | 1.02% | 0.08% | 1.34% | 2024-12-31 |
| CITADEL ADVISORS LLC | 598.90 tis | 0.99% | 0.00% | 0.01% | 2024-06-30 |
| MORGAN STANLEY | 595.03 tis | 0.98% | 0.00% | 0.00% | 2023-09-30 |
| JEFFERIES FINANCIAL GROUP INC. | 568.08 tis | 0.97% | -0.13% | 0.11% | 2024-06-30 |
| JENNISON ASSOCIATES LLC | 585.02 tis | 0.96% | 0.01% | 0.03% | 2023-12-31 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 576.68 tis | 0.95% | 2.71% | 4.35% | 2025-12-31 |
| EVENTIDE ASSET MANAGEMENT, LLC | 557.42 tis | 0.92% | 0.26% | 0.78% | 2025-12-31 |
| SOFINNOVA INVESTMENTS, INC. | 534.85 tis | 0.91% | 0.51% | 1.74% | 2025-06-30 |
| POLAR CAPITAL HOLDINGS PLC | 539.18 tis | 0.89% | 0.01% | 0.16% | 2025-03-31 |
| AVORO CAPITAL ADVISORS LLC | 500.00 tis | 0.85% | 0.36% | 0.36% | 2025-12-31 |
| FIRST TURN MANAGEMENT, LLC | 513.77 tis | 0.85% | 0.74% | 4.83% | 2024-03-31 |
| BRAIDWELL LP | 478.67 tis | 0.79% | -0.04% | 1.34% | 2023-09-30 |
| NOVO HOLDINGS A/S | 450.00 tis | 0.74% | -0.27% | 3.07% | 2025-06-30 |
| FEDERATED HERMES, INC. | 442.74 tis | 0.73% | 0.04% | 0.06% | 2025-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 438.65 tis | 0.72% | 0.05% | 0.05% | 2025-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 420.68 tis | 0.69% | 0.00% | 0.01% | 2023-09-30 |
| FRANKLIN RESOURCES INC | 405.54 tis | 0.67% | 0.00% | 0.01% | 2023-09-30 |
| 396.33 tis | 0.65% | 0.00% | 0.00% | 2026-03-31 | |
| NORTHERN TRUST CORP | 390.88 tis | 0.64% | 0.00% | 0.00% | 2023-09-30 |
| OPALEYE MANAGEMENT INC. | 390.00 tis | 0.64% | 0.46% | 4.32% | 2025-09-30 |
| GREAT POINT PARTNERS LLC | 374.00 tis | 0.62% | -1.92% | 7.23% | 2025-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 368.96 tis | 0.61% | 0.01% | 0.01% | 2026-03-31 |
| LOOMIS SAYLES & CO L P | 362.78 tis | 0.60% | 0.02% | 0.04% | 2025-12-31 |
| CAPTION MANAGEMENT, LLC | 362.60 tis | 0.60% | 0.18% | 0.18% | 2024-03-31 |
| CAPITAL WORLD INVESTORS | 348.67 tis | 0.57% | 0.00% | 0.00% | 2024-12-31 |
| LOGOS GLOBAL MANAGEMENT LP | 300.00 tis | 0.54% | 1.59% | 1.59% | 2024-12-31 |
| COMMODORE CAPITAL LP | 290.00 tis | 0.50% | -0.33% | 0.56% | 2023-09-30 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 298.65 tis | 0.49% | -9.95% | 1.82% | 2023-09-30 |
| DEEP TRACK CAPITAL, LP | 285.00 tis | 0.47% | 0.39% | 0.39% | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 281.39 tis | 0.46% | 0.01% | 0.02% | 2023-12-31 |
| WOODLINE PARTNERS LP | 261.12 tis | 0.43% | 0.02% | 0.08% | 2023-09-30 |
| PICTET ASSET MANAGEMENT HOLDING SA | 261.05 tis | 0.43% | 0.00% | 0.02% | 2025-12-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 250.00 tis | 0.41% | 0.01% | 0.03% | 2023-09-30 |
| IKARIAN CAPITAL, LLC | 232.05 tis | 0.40% | 1.94% | 1.94% | 2025-06-30 |
| VICTORY CAPITAL MANAGEMENT INC | 217.21 tis | 0.37% | 0.00% | 0.01% | 2023-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 215.85 tis | 0.37% | 0.00% | 0.01% | 2024-06-30 |
| DIADEMA PARTNERS LP | 211.10 tis | 0.36% | 1.45% | 2.74% | 2025-03-31 |
| BANK OF NEW YORK MELLON CORP | 201.15 tis | 0.34% | 0.00% | 0.00% | 2023-09-30 |
| TANG CAPITAL MANAGEMENT LLC | 200.00 tis | 0.34% | -0.13% | 0.31% | 2024-03-31 |
| D. E. SHAW & CO., INC. | 194.53 tis | 0.33% | 0.01% | 0.01% | 2024-06-30 |
| BLACKSTONE INC. | 190.35 tis | 0.33% | 0.00% | 0.03% | 2023-09-30 |
| CANDRIAM S.C.A. | 191.32 tis | 0.33% | 0.05% | 0.07% | 2025-09-30 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 167.99 tis | 0.29% | 0.02% | 0.02% | 2024-06-30 |
| AMERIPRISE FINANCIAL INC | 156.11 tis | 0.27% | 0.00% | 0.00% | 2024-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 152.70 tis | 0.26% | 0.00% | 0.00% | 2024-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 137.83 tis | 0.25% | 0.00% | 0.00% | 2023-09-30 |
| MILLENNIUM MANAGEMENT LLC | 140.73 tis | 0.24% | 0.00% | 0.00% | 2023-12-31 |
| SG AMERICAS SECURITIES, LLC | 134.23 tis | 0.23% | 0.02% | 0.02% | 2025-09-30 |
| TD ASSET MANAGEMENT INC | 126.45 tis | 0.23% | 0.00% | 0.01% | 2023-09-30 |
| BARCLAYS PLC | 133.19 tis | 0.23% | 0.00% | 0.00% | 2023-12-31 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 132.40 tis | 0.23% | -0.02% | 0.22% | 2024-09-30 |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 131.44 tis | 0.23% | 0.00% | 0.01% | 2024-12-31 |
| ARROWMARK COLORADO HOLDINGS LLC | 109.41 tis | 0.20% | -0.02% | 0.07% | 2023-09-30 |
| ALLOSTERY INVESTMENTS LP | 100.00 tis | 0.18% | 4.73% | 4.73% | 2024-12-31 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 95.65 tis | 0.17% | -0.03% | 0.25% | 2023-09-30 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 87.95 tis | 0.16% | 0.00% | 0.00% | 2023-09-30 |
| PARKMAN HEALTHCARE PARTNERS LLC | 85.00 tis | 0.15% | 0.51% | 0.51% | 2024-12-31 |
| MARSHALL WACE, LLP | 75.85 tis | 0.14% | 0.00% | 0.00% | 2024-06-30 |
| KENNEDY CAPITAL MANAGEMENT LLC | 72.31 tis | 0.13% | 0.02% | 0.07% | 2024-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 70.77 tis | 0.13% | 0.02% | 0.02% | 2024-12-31 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 70.00 tis | 0.13% | 0.20% | 0.20% | 2024-12-31 |
| ENSIGN PEAK ADVISORS, INC | 69.75 tis | 0.13% | 0.00% | 0.01% | 2024-03-31 |
| RAFFERTY ASSET MANAGEMENT, LLC | 57.67 tis | 0.10% | 0.00% | 0.01% | 2024-03-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 1341 | 82.58 | 15.5 2026 | 1115987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 18659 | 82.05 | 15.5 2026 | 1117328 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 8.5 2026 | 123040 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 1800 | 84.60 | 8.5 2026 | 207023 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 3700 | 83.92 | 8.5 2026 | 208823 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 8.5 2026 | 212523 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 289 | 83.16 | 4.5 2026 | 173371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 900 | 82.60 | 4.5 2026 | 173660 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 811 | 81.02 | 4.5 2026 | 174560 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | M-Exempt | 3000 | 22.86 | 20.4 2026 | 387012 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | M-Exempt | 3000 | 22.86 | 20.4 2026 | 1135987 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 2000 | 90.00 | 17.4 2026 | 175371 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 200 | 85.00 | 10.4 2026 | 1132987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 2000 | 83.26 | 10.4 2026 | 1133187 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 17800 | 82.48 | 10.4 2026 | 1135187 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1100 | 85.46 | 3.4 2026 | 177371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 900 | 84.46 | 3.4 2026 | 178471 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 3.4 2026 | 127165 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 100 | 85.89 | 3.4 2026 | 208398 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2702 | 85.33 | 3.4 2026 | 208498 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2698 | 84.31 | 3.4 2026 | 211200 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 3.4 2026 | 213898 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 2000 | 85.00 | 27.3 2026 | 179371 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 3418 | 75.86 | 13.3 2026 | 1152987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 8219 | 74.83 | 13.3 2026 | 1156405 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 8363 | 74.29 | 13.3 2026 | 1164624 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 6.3 2026 | 131290 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 200 | 73.26 | 6.3 2026 | 209773 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2075 | 71.98 | 6.3 2026 | 209973 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 3225 | 70.33 | 6.3 2026 | 212048 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 6.3 2026 | 215273 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 406 | 71.66 | 4.3 2026 | 181371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 994 | 70.45 | 4.3 2026 | 181777 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 300 | 69.43 | 4.3 2026 | 182771 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 300 | 68.27 | 4.3 2026 | 183071 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 955 | 64.99 | 13.2 2026 | 1172987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 7551 | 63.73 | 13.2 2026 | 1173942 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 11494 | 62.96 | 13.2 2026 | 1181493 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 100 | 66.89 | 4.2 2026 | 183371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1108 | 66.15 | 4.2 2026 | 183471 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 792 | 65.21 | 4.2 2026 | 184579 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 4.2 2026 | 135415 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 200 | 68.94 | 4.2 2026 | 211148 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 100 | 67.88 | 4.2 2026 | 211348 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 1299 | 66.85 | 4.2 2026 | 211448 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 1420 | 65.83 | 4.2 2026 | 212747 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2481 | 64.88 | 4.2 2026 | 214167 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4125 | 22.86 | 4.2 2026 | 216648 |
| Fairmount Funds Management LLC | director | S-Sale | 1750000 | 76.30 | 22.1 2026 | 298647 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 470 | 83.79 | 16.1 2026 | 1192987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 5386 | 83.16 | 16.1 2026 | 1193457 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 1854 | 82.41 | 16.1 2026 | 1198843 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 2374 | 81.00 | 16.1 2026 | 1200697 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 8476 | 79.82 | 16.1 2026 | 1203071 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 1440 | 78.64 | 16.1 2026 | 1211547 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 14025 | 22.86 | 9.1 2026 | 139540 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 100 | 80.06 | 9.1 2026 | 212523 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 826 | 79.04 | 9.1 2026 | 212623 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 14820 | 77.90 | 9.1 2026 | 213449 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2954 | 77.13 | 9.1 2026 | 228269 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 14025 | 22.86 | 9.1 2026 | 231223 |
| Henderson Jane | officer: Chief Financial Officer | A-Award | 83690 | 75.78 | 6.1 2026 | 83690 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 2000 | 80.00 | 6.1 2026 | 185371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 4080 | 75.20 | 6.1 2026 | 187371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1920 | 74.13 | 6.1 2026 | 191451 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | A-Award | 253016 | 75.78 | 6.1 2026 | 253016 |
| Dambkowski Carl | officer: Chief Medical Officer | A-Award | 83690 | 75.78 | 6.1 2026 | 83690 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1500 | 80.00 | 23.12 2025 | 193371 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 560 | 76.58 | 12.12 2025 | 1212987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 10005 | 75.79 | 12.12 2025 | 1213547 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 9435 | 74.88 | 12.12 2025 | 1223552 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 40000 | 75.01 | 5.12 2025 | 1232987 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1500 | 75.00 | 5.12 2025 | 194871 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 10900 | 75.00 | 5.12 2025 | 271108 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1500 | 70.00 | 28.11 2025 | 196371 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 2000 | 65.00 | 14.11 2025 | 197871 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 100 | 64.52 | 13.11 2025 | 1272987 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 1786 | 63.89 | 13.11 2025 | 1273087 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 14774 | 63.14 | 13.11 2025 | 1274873 |
| HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | S-Sale | 3340 | 61.93 | 13.11 2025 | 1289647 |
| Henderson Jane | officer: Chief Financial Officer | S-Sale | 1000 | 60.00 | 13.11 2025 | 199871 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 8060 | 22.86 | 7.11 2025 | 153565 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 678 | 56.51 | 7.11 2025 | 282008 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 5607 | 55.58 | 7.11 2025 | 282686 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2200 | 54.83 | 7.11 2025 | 288293 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2300 | 53.62 | 7.11 2025 | 290493 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 8060 | 22.86 | 7.11 2025 | 292793 |
| Shah Nimish P | director | P-Purchase | 365853 | 0.00 | 15.10 2025 | 365853 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 2385 | 22.86 | 3.10 2025 | 161625 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 5110 | 39.80 | 3.10 2025 | 284733 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 2385 | 22.86 | 3.10 2025 | 289843 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 190 | 38.55 | 5.9 2025 | 233548 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2535 | 37.82 | 5.9 2025 | 233738 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2725 | 37.78 | 8.8 2025 | 236273 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 7365 | 22.86 | 3.7 2025 | 164010 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 746 | 46.26 | 3.7 2025 | 238998 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 2935 | 45.49 | 3.7 2025 | 239744 |
| Dambkowski Carl | officer: Chief Medical Officer | S-Sale | 6409 | 44.77 | 3.7 2025 | 242679 |
| Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 7365 | 22.86 | 3.7 2025 | 249088 |
| Fairmount Funds Management LLC | director | A-Award | 14461 | 41.66 | 20.6 2025 | 14461 |
